Kimia Biosciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kimia Biosciences Ltd. on BSE

Load latest

Kimia Biosciences Ltd.

02 Aug 2024

39.48

-4.48%

Corp. Note

Kimia Biosciences Ltd - 530313 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Dear Sir/ Madam, This is with reference to the earlier intimation dated 30.07.2024 regarding the request received for issuance of duplicate share certificate in lieu of the loss original share certificates.

pdf

Kimia Biosciences Ltd.

30 Jul 2024

39.48

-4.48%

Corp. Note

Kimia Biosciences Ltd - 530313 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Dear Sir/ Madam, Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The Company has received the intimation from our Registrar & Transfer Agent, Beetal Financial Computers Services Private Limited regarding they issuance of duplicate share certificates.

pdf

Kimia Biosciences Ltd.

08 Jul 2024

39.48

-4.48%

Company Update

Kimia Biosciences Ltd - 530313 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Dear Sir/ Madam, Pursuant to Regulation 74(5) of SEBI (Depositories and Participants Regulations, 2018, please find enclosed a copy of certificate for the quarter and three months ended June 30, 2024 received from Beetal Financial & Computers Services Private Limited, RTA of the Company.

pdf

Kimia Biosciences Ltd.

29 Jun 2024

39.48

-4.48%

SAST

Kimia Biosciences Ltd - 530313 - Closure of Trading Window

BSE India

Dear Sir/ Madam, Pursuant to Company'' code of prevention of Insider Trading, the trading window in securities of the Company shall remain closed from Monday, July 01, 2024, till the expiry of 48 hours after the declaration of un-audited financial results ( standalone) for the quarter ended June 30, 2024.

pdf

Kimia Biosciences Ltd.

28 Jun 2024

39.48

-4.48%

Company Update

Kimia Biosciences Ltd - 530313 - Information Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, the Board of Directors of the Company at their meeting held on June 28, 2024 on the recommendation of the Audit Commitee, inter alia considered and subject to the approval of the shareholders at the ensuing Annual General Meeting approved the appointment of Sunil Suresh & Associates, Chartered Accountants as the Statutory Auditors of the Company to fill the casual vacancy of the Company.

pdf

Kimia Biosciences Ltd.

28 Jun 2024

39.48

-4.48%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of Board Meeting.

BSE India

Dear Sir/Madam, The meeting of Board of Directors of the Company was held today on Friday, June 28, 2024 at 12.00 pm (IST) at the corporate office of the Company, situated at 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subash Place, New Delhi-110034 and the following businesses, amongst others, were transacted at the meeting of the Board of Directors. 1. Appointment of Sunil Suresh & Associates, Chartered Accountants as Statutory Auditors of the Company to fill the casual vacancy on the recommendation of the Audit Committee. The Appointment is subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.

pdf

Kimia Biosciences Ltd.

22 Jun 2024

39.48

-4.48%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Intimation Of Board Meeting

BSE India

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2024 ,inter alia, to consider and approve This is to inform that a meeting of Board of Directors is scheduled to be held on Friday, June 28, 2024 at 12.00 pm (IST) at the corporate office of the Company 974, 9th Floor, Aggarwal Millennium Tower-II, Netaji Subhash Place, Pitampura, New Delhi-110034 to transact the following businesses, amongst others: 1) To consider and short listing the firm for appointment of Statutory Auditors of the Company arose due to casual vacancy. 2) Any other matter as may be considered and transacted with permission of Board of Directors.

pdf

Kimia Biosciences Ltd.

14 Jun 2024

39.48

-4.48%

Company Update

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Filing Of Declaration Of Unmodified Opinion.

BSE India

The Company refer to our earlier submission of the audited standalone financial results for the quarter and year ended March 31, 2024, which was filed on 30.05.2024. It has come to the attention that the declaration of an unmodified opinion was inadvertently missed out due to technical snag during the filing process. We deeply regret this insight and any inconvenience it may have caused. Please find attached complete set of audited standalone financial results for the quarter and year ended March 31, 2024, including declaration of unmodified opinion. You are requested to kindly take this in your records.

pdf

Kimia Biosciences Ltd.

12 Jun 2024

39.48

-4.48%

Corp. Note

Kimia Biosciences Ltd - 530313 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Dear Sir/ Madam, Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The Company has received the intimation from our Registrar & Transfer Agent.

pdf

Kimia Biosciences Ltd.

01 Jun 2024

39.48

-4.48%

Company Update

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Dear Sir/ Madam, Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find Newspaper publications of Audited Financial Results for the quarter and year ended March 31, 2024 in following newspapers.

pdf

No results found

Is Kimia Biosciences Ltd. worth buying?

14 Votes:

Buy 71.43%

Sell 7.14%

Hold 21.43%